Angiogenin Levels and ANG Genotypes: Dysregulation in Amyotrophic Lateral Sclerosis
Open Access
- 10 November 2010
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 5 (11) , e15402
Abstract
To determine whether 5 single nucleotide polymorphisms (SNPs) associate with ALS in 3 different populations. We also assessed the contribution of genotype to angiogenin levels in plasma and CSF. Allelic association statistics were calculated for polymorphisms in the ANG gene in 859 patients and 1047 controls from Sweden, Ireland and Poland. Plasma, serum and CSF angiogenin levels were quantified and stratified according to genotypes across the ANG gene. The contribution of SNP genotypes to variance in circulating angiogenin levels was estimated in patients and controls. All SNPs showed association with ALS in the Irish group. The SNP rs17114699 replicated in the Swedish cohort. No SNP associated in the Polish cohort. Age- and sex-corrected circulating angiogenin levels were significantly lower in patients than in controls (pANG variants associate with ALS in the Irish and Swedish populations, but not in the Polish. There is evidence of dysregulation of angiogenin expression in plasma and CSF in sporadic ALS. Angiogenin expression is likely to be important in the pathogenesis of ALS.Keywords
This publication has 24 references indexed in Scilit:
- Identification of new ANG gene mutations in a large cohort of Italian patients with amyotrophic lateral sclerosisneurogenetics, 2007
- Human angiogenin is a neuroprotective factor and amyotrophic lateral sclerosis associated angiogenin variants affect neurite extension/pathfinding and survival of motor neuronsHuman Molecular Genetics, 2007
- Angiogenin loss‐of‐function mutations in amyotrophic lateral sclerosisAnnals of Neurology, 2007
- Elevated serum angiogenin levels in ALSNeurology, 2006
- ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosisNature Genetics, 2006
- Cerebrospinal fluid vascular endothelial growth factor in patients with amyotrophic lateral sclerosisClinical Neurology and Neurosurgery, 2004
- Low levels of the vascular endothelial growth factor in CSF from early ALS patientsNeurology, 2004
- New roles for VEGF in nervous tissue?beyond blood vesselsExperimental Neurology, 2004
- VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic deathNature Genetics, 2003
- Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degenerationNature Genetics, 2001